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Abstract
Streptococcus agalactiae, also referred to as Group B Streptococcus, is a frequent resident of the rectovaginal tract in
humans, and a major cause of neonatal infection. The pathogen can also infect adults with underlying disease,
particularly the elderly and immunocompromised ones. In addition, S. agalactiae is a known fish pathogen, which
compromises food safety and represents a zoonotic hazard. This study provides valuable structural, functional and
evolutionary genomic information of a human S. agalactiae serotype Ia (ST-103) GBS85147 strain isolated from the
oropharynx of an adult patient from Rio de Janeiro, thereby representing the first human isolate in Brazil. We used
the Ion Torrent PGM platform with the 200 bp fragment library sequencing kit. The sequencing generated
578,082,183 bp, distributed among 2,973,022 reads, resulting in an approximately 246-fold mean coverage depth
and was assembled using the Mira Assembler v3.9.18. The S. agalactiae strain GBS85147 comprises of a circular
chromosome with a final genome length of 1,996,151 bp containing 1,915 protein-coding genes, 18 rRNA, 63 tRNA,
2 pseudogenes and a G + C content of 35.48 %.
Keywords: Streptococcus agalactiae, Human pathogenic bacteria, Oropharynx, Complete genome sequence, Ion torrent
Abbreviations: CPS, Capsular polysaccharides; GBS, Group B Streptococcus; NT, Not type; PGM, Personal genome machine.
Introduction
Streptococcus agalactiae is a bacterial pathogen, distrib-
uted worldwide, that causes diseases in humans and ani-
mals [1]. In humans, it is frequently associated with
meningitis, neonatal sepsis and may also affect immuno-
compromised adults and the elderly [2]. S. agalactiae is
responsible for the most fatal bacterial infections in
human newborns [3]. In fish, the pathogen causes menin-
goencephalitis and septicemia worldwide, in both fresh-
water and salt-water species [4, 5]. Consumption of fish
has been associated with an increased risk of colonization
by S. agalactiae serotypes Ia and Ib in people [6]. S. aga-
lactiae continues to be a major cause of subclinical
mastitis in dairy cattle, which is the dominant health dis-
order affecting milk production in the dairy industry, and
is responsible for substantial financial losses in that indus-
try worldwide [7].
S. agalactiae is of great medical and veterinary import-
ance due to a high social and economic impact [8],
together with the incidence of diesase in different hosts
[9]. The incidence of invasive infections unrelated to
pregnancy in human adults and animals is increasing
worldwide [10]. Therefore, further studies in the area
remains necessary. Since the 1990s, serotype V emerged
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in the United States as the most frequent S. agalactiae
serotype causing invasive disease in nonpregnant adults
[11]. Nowadays, other serotypes including Ia and III have
also been recognized in different countries as significant
cause of invasive diseases [12]. Comparative genomic stud-
ies among several S. agalactiae strains of the different sero-
types will contribute to a better understanding of the
biological complexity of the species. One such reason drove
this study for genome sequencing, assembly and annotation
of the GBS85147 S. agalactiae serotype Ia and Sequence
Type 103 (ST-103) strain. The pathogenic potential of this
human isolate obtained from the oropharynx of an asymp-
tomatic female patient suffering of various recurrent
pharyngitis episodes has been increasingly observed in dif-
ferent investigations [13–16]. From six S. agalactiae strains
of Ia, III and V serotypes, only serotype Ia, including strain
GBS85147, was capable of triggering a respiratory oxidative
burst during adherence to the surface of activated macro-
phages. This activity was demonstrated by NADPH-oxidase
activation within phagocytic vacuoles, indicating a high
ability of strain GBS85147 isolated from an asymptomatic
patient to survive in aerobic stress conditions. Moreover,
Fig. 1 SEM photomicrograph of S. agalactiae Gbs85147. Scanning electron microscopy of Streptococcus agalactiae strain GBS85147 grown in
liquid media after 8 h. Scale bars, 2 and 30 μm, respectively
Fig. 2 Phylogenetic tree of S. agalactiae GBS85147 strain representing its position relative to other type strains. The phylogenetic tree was
generated using S. agalactiae GBS85147 strain, 21 strains of Streptococcus agalactiae, and 3 strains from the genus Streptococcus as outgroup
strains available at GenBank. The align and tree were constructed with CLC Genomic Workbench using Neighbor Joining method and
Jukes-Cantor measure of nucleotide distance with 1000 bootstrap replications
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the invasive potential of strain GBS85147 was also demon-
strated by bacterial adherence, invasion and survival
(24 h) in the intracytoplamatic environment of endothelial
cells. Moreover, the detection of sialic acid in bacteria is
limited to a few examples, which, strikingly, are all patho-
genic, including S. agalactiae. Similar to serotypes III and
V, sialic acid residues were also detected on the surface of
serotype Ia GBS85147 strain. These findings reinforce the
pathogenic potential of S. agalactiae GBS85147 strain by
its ability to interfere specifically with opsonic compo-
nents due to inhibition of the alternative complement
pathway by serum deficient in a specific antibody [16, 17].
Organism information
Classification and features
S. agalactiae is a Gram stain-positive, non-sporulating
bacterium having a spherical shape with dimensions ran-
ging from 0.2 to 1.0 microns [10] in diameter. On solid
medium, S. agalactiae may form short chains or may form
groups of double cocci. In liquid cells, the microorganism
can form long chains (Fig. 1). The bacterium is a facultative
anaerobe, catalase and oxidase negative, and is capable of
lactic acid fermentation [18]. Lancefield identified the group
B antigen, a peptidoglycan-anchored antigen (rhamnose,
galactose, N-acetylglucosamine, and glucitol), that defines
the S. agalactiae species [19, 20].
A capsular polysaccharide antigen is used to classify S.
agalactiae strains into serotypes [21]. The structure of the
CPS is determined by genes encoding the enzymes
responsible for its synthesis [22]. Serotype classification is
based on the capsular antigen differences detected by PCR
or by immunodiffusion techniques [23]. Currently, ten
serotypes have been described (Ia, Ib, II, III, IV, V, VI, VII,
VIII, IX); serotype IX was identified in 2007 [24]. In some
strains, serotype identification is not possible due to the
absence of the polysaccharide, caused by a mutation in the
capsular genes [25]. The high degree of variation in the
capsular structure is related to the virulence of different
strains of S. agalactiae [26]. Those variations in the capsu-
lar structure may also explain its infection of unusual hosts
such as camels, dogs, horses, seals, chickens, dolphins, cats,
hamsters, frogs, and monkeys [9].
Table 1 Classification and general features of S. agalactiae strain
GBS85147 – MIGS [27]
MIGS ID Property Term Evidence codea
Classification Domain Bacteria TAS [47]
Phylum Firmicutes TAS [48]
Class Bacilli TAS [49]










Gram stain Positive IDA [10]
Cell shape Coccus-shaped IDA [18]
Motility Non-motile IDA [10]









5.4 – 9.4; 7.4 IDA
Carbon source Not Reported NAS [19]
MIGS-6 Habitat Human pharynx IDA [8]
MIGS-6.3 Salinity 4.0 to 6.0 % IDA [54]
MIGS-22 Oxygen
requirement
Facultative anaerobe IDA [18]
MIGS-15 Biotic relationship Symbiotic IDA [8]
MIGS-14 Pathogenicity Pathogen IDA [13]
MIGS-4 Geographic
location




MIGS-4.1 Latitude Not reported IDA
MIGS-4.2 Longitude Not reported IDA
MIGS-4.4 Altitude Not reported IDA
aEvidence codes - IDA inferred from direct assay, TAS traceable author
statement (i.e., a direct report exists in the literature), NAS non-traceable
author statement (i.e., not directly observed for the living, isolated sample,
but based on either a generally accepted property for the species or
anecdotal evidence). These evidence codes are from the Gene Ontology
project [55]
Table 2 Project information
MIGS ID Property Term
MIGS-31 Finishing quality Finished
MIGS-28 Libraries used Fragment
MIGS-29 Sequencing platforms Ion Torrent™ PGM System
MIGS-31.2 Fold coverage 246x
MIGS-30 Assemblers Mira v3.9.18
MIGS-32 Gene calling method FgenesB
Locus tag GBS85147
Genbank ID CP010319
Genbank Date of Release 05/01/2015
GOLD ID
BIOPROJECT PRJNA263907
MIGS 13 Source Material Identifier SAMN03108598
Project relevance Medical, Veterinary,
Biotechnological
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A phylogenetic analysis was performed using, in total 25
different strains, including S. agalactiae GBS85147 strain,
plus 21 strains of Streptococcus agalactiae, and 3 strains
from the genus Streptococcus, as outgroup strains, available
at GenBank. The 16S rRNA genes, with mean length of
1,526 ± 50 bp, were aligned with CLC Genomics Work-
bench (Qiagen, USA). The phylogenetic tree was generated
in the same software with the Neighbor Joining method
and Jukes-Cantor measure of nucleotide distance with
1,000 bootstrap replications. The phylogenetic tree demon-
strates the placement of GBS85147 strain with other closely
related strains from the same species, forming a specific
clade in 100 % of replications, while it remained distant
from the Streptococcus spp. equi, suis, and pyogenes (Fig. 2).
All 16S rRNA genes found on assembled contigs were in
an equal form. Through this data we observed no contam-
ination and evidence of correct identification of GBS85147
strain. Other features of the strain can be viewed in Table 1.
Genome sequencing information
Genome project history
S. agalactiae strain GBS85147, taken from a human
oropharynx, was isolated in the Laboratory of Molecular
Fig. 3 Map of Circular genome generated with CGview comparison tool. In the outermost ring the genes identified by the COG, followed by
Blue CDS, tRNAs in orange, rRNAs in pink, other RNAs in gray. In the intermediate ring GC content in black and the innermost ring represents
the GC skew + in green and GC skew- in purple
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Biology and Physiology of Streptococci in the city of Rio de
Janeiro, RJ, Brazil. The genome was sequenced, assembled
and annotated at the Laboratory of Cellular and Molecular
Genetics in collaboration with the National Reference
Laboratory for Aquatic Animal Diseases, Ministry of Fish-
eries and Aquaculture, both located at the Federal Univer-
sity of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
The genome project was deposited to the public database
and the complete genome sequence is available in the Gen-
Bank under the accession number Genbank ID CP010319.
Further, project information and association with MIGS
version 2.0 compliance [27], are summarized in Table 2.
Growth conditions and genomic DNA preparation
S. agalactiae GBS85147 was obtained from the Strepto-
coccus bacterial collection of the Laboratory of Molecular
Biology and Physiology of Streptococci. The sample was
grown on 30 mL of brain-heart-infusion broth (BHI-
HiMedia Laboratories Pvt. Ltda, India), with shaking for
48 h at 37 °C. Chromosomal DNA was extracted from
30 ml of bacterial culture. Briefly, the culture was centri-
fuged at 4 °C, 4000 rpm, for 15 min. Cell pellets were re-
suspended in 600 μL Tris/EDTA/NaCl [10 mMTris/HCl
(pH7.0), 10 mM EDTA (pH8.0), and 300 mMNaCl],
placed 2 times in tubes containing lysed cells with
Precellys® at rotations of 6500 rpm for 30 s. The DNA was
purified using phenol/chloroform/isoamyl alcohol (25:24:1),
precipitated using ethanol/NaCl/glycogen (2.5 vol ethanol,
10 % NaCl and 1 % glycogen) and re-suspended in 30 μL
MilliQ®. Finally, the DNA was stained using ethidium
bromide and visualized in 1 % agarose gel [28].
Genome sequencing and assembly
Genome sequencing was performed using a fragment
library with the Ion Torrent™ Personal Genome Machine
System, with 200 bp sequencing kit. The sequencing
produced a total of 578,082,183 bp, distributed among
2,973,022 reads, with an average genome coverage depth
of 246-fold and a Phred quality greater than or equal to
20 in 91.25 % of bases. De novo assembly was performed
using Mira v3.9.18 [29]. The assembly resulted in 104
contigs, accounting for 2,032,890 bp and an N50 of
104.996 bp.
Twenty of the contigs obtained were randomly used as
query on BlastN+ [30], over NR database to identify the
most similar S. agalactiae complete genome deposited
in GenBank. After that, the contigs were ordered and
oriented using the software CONTIGuator v2 [31] with
S. agalactiae GD201008-001 [32] as a reference genome,
generating a pseudo chromosome with 31 scaffolds. The
remaining gaps were closed removing overlaps of neigh-
boring contigs and via consensus sequences obtained by
Table 3 Genome statistics
Attribute Value % of Total
Genome size (bp) 1,996,151 100.00
DNA coding (bp) 1,804,165 90.38
DNA G + C (bp) 708,380 35.48
DNA scaffolds 1 100.00
Total genes 1,998 100.00
Protein coding genes 1,915 95.84
RNA genes 81 4.05
Pseudogenes 2 0.1
Genes in internal clusters 26 1.30
Genes with function prediction 1,713 85.73
Genes assigned to COGs 1,564 78.27
Genes with Pfam domains 1,651 82.63
Genes with signal peptides 111 5.55
Genes with transmembrane helices 511 25.57
CRISPR repeats 1
Table 4 Number of genes associated with general COG
functional categories
Code Value % age Description
J 144 6.63 Translation, ribosomal structure and biogenesis
A 0 0.00 RNA processing and modification
K 115 5.29 Transcription
L 97 4.46 Replication, recombination and repair
B 1 0.05 Chromatin structure and dynamics
D 20 0.92 Cell cycle control, Cell division,
chromosome partitioning
V 36 1.66 Defense mechanisms
T 61 2.81 Signal transduction mechanisms
M 106 4.88 Cell wall/membrane biogenesis
N 7 0.32 Cell motility
U 30 1.38 Intracellular trafficking and secretion
O 58 2.67 Posttranslational modification, protein
turnover, chaperones
C 52 2.39 Energy production and conversion
G 173 7.96 Carbohydrate transport and metabolism
E 155 7.13 Amino acid transport and metabolism
F 74 3.41 Nucleotide transport and metabolism
H 50 2.30 Coenzyme transport and metabolism
I 49 2.25 Lipid transport and metabolism
P 102 4.69 Inorganic ion transport and metabolism
Q 23 1.06 Secondary metabolites biosynthesis,
transport and catabolism
R 219 10.08 General function prediction only
S 167 7.69 Function unknown
- 434 19.97 Not in COGs
The total is based on the total number of protein coding genes in the genome
de Aguiar et al. Standards in Genomic Sciences  (2016) 11:39 Page 5 of 8
mapping the raw data against the reference genome using
CLC Genomics Workbench 7.0 (Qiagen, USA) [33] and
BlastN. Furthermore, only the consensus data was used to
close gaps in the rRNA regions.
Genome annotation
Structural gene prediction was performed using the FGE-
NESB [34]. To choose a reference, twenty random parts of
our genome were used as query on BlastN over the avail-
able four S. agalactiae genomes on FGENESB. Therefore,
using S. agalactiae 09mas018883 [35] as reference, the
prediction resulted in 1,616 genes. The genome annota-
tion was performed manually with Artemis [36], UniProt
databases [37] and Interproscan 5 [38]. During manual
annotation, 299 additional genes were added. For the
prediction of rRNA and tRNA the software RNAmmer
v1.2 [39] and tRNAscan-SE [40] were used, respectively.
Genome properties
The genome has one circular chromosome with
1,999,151pb, 35.48 % G +C content, a total of 1,998 CDS,
including 1,915 protein-coding genes, 18 rRNAs, 63
tRNAs and 2 pseudogenes. A circular map of the genome
was generated using the CGView Comparison Tool [41],
shown in Fig. 3. Genome statistics are summarized in
Tables 3 and 4. Functional analysis using the COG base
showed that approximately 27 % of the genes do not have
any described function, which consists in the sum of genes
with unknown functions (7.69 %) and genes that were not
found in the database (19.97 %).
Insight from the genome sequence
To predict pathogenic islands, GIPSy software [42] was
used. GBS85147 strain was compared against 16 complete
strains of the same species found at GenBank. BRIG
software [43], was used to view the circular structure of
pathogenic Islands and the genome strains. Figure 4a rep-
resents the seven predicted pathogenicity islands; espe-
cially pathogenicity island 4 that consists of six genes,
representing four conserved hypothetical proteins whereas
two of them are not conserved in all strains. The first one
is “Streptokinase”, an enzyme usually secreted by Strepto-
coccus species and has a high therapeutic potential to com-
bat thrombolysis, also currently used to combat heart
attack and pulmonary embolism [44]. The second “Glycine
betaine/proline transport system”, makes part of the glycine
betaine transport complex [45]. Glycine is involved in the
formation of the peptidoglycan cell wall of Gram-positive
bacteria and also helps in securing external cell structures
[46], indicating that the bacteria have evolved abilities
to survive the stress within the host cells, becoming
more resistant to the intracellular environment. Figure 4b
Fig. 4 a. Predicted pathogenic and genomic islands and comparative visualization. Representation of the seven pathogenic islands predicted by Gipsy
software comparing the S. agalactiae GBS85147 strain against the 16 complete genomes of the S. agalactiae species obtained from the NCBI database.
b. Representation of the eight genomic islands predicted using the same software by comparing the S. agalactiae GBS85147 strain against the 16
complete genomes of the S. agalactiae species obtained from the NCBI database. From the inner to outer ring (black) we used the genome of S.
agalactiae GBS85147 strain as a reference, followed by GC - (purple) and GC + (green) content, the strains of S. agalactiae 09mas018883 [35], 138P [56],
138spar [57], 2603 V/R [58], A909 [59], CNCTC10/84 [60], COH1 [61], GBS1-NY [62], GBS2-NM [62], GBS6 [62], GD201008-001 [32], ILRI005 [63], ILRI112
[63], NGBS061 [64], NGBS572 [64] and SA20-06 [65] respectively. The last external ring in 4A display the pathogenic islands while the last external ring
in 4B display the genomic islands, respectively
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(Additional file 1) shows eight genomic islands of
unknown classification. This result indicates that Gipsy
recognized the region as a probable genomic island, but
could not identify it. An in-depth analysis of the genes
present in this island revealed that much of the genes
products hypothetical proteins, highlighting an import-
ance of conducting further studies for genes present in
this region in order to better characterize their functions.
Conclusion
The genome sequence of S. agalactiae GBS85147, obtained
using the Ion Torrent PGM platform with approximately
246-fold coverage, was completely finished, manually anno-
tated, its putative pseudogenes manually curated and the
resulting genome file deposited in NCBI. After manual
annotation of CDSs, the function of 1,713 (85.73 %) genes
was identified and, after frameshift manual curation, only
two pseudogenes remained. The final size of the genome is
~2 Mb with G +C content of 35.48 %, consistent with the
genomes of other strains of the S. agalactiae species.
The complete genome of GBS85147, the first isolate of
oropharynx of an adult patient in Brazil, can help in
further understanding the dissemination of this disease,
and improve the identification of genes that allow the S.
agalactiae serotype Ia to trigger the respiratory oxidative
burst during adherence to the surface of activated macro-
phages. Furthermore, our data may become valuable to
future comparative studies with other S. agalactiae strains
of different serotypes in order to explore their virulence
determinants, evolutionary relationships and the genetic
basis of host tropism in S. agalactiae.
Additional file
Additional file 1: Strain ID Summary. (DOC 26 kb)
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